CSL Appoints New Director

CSL Appoints New Director

Melbourne, Australia — 20/07/2004

CSL today announced that Mr Maurice Renshaw had been appointed a Director and would join the CSL Board effective immediately.

An Australian, Mr Renshaw has more than 30 years experience in the international pharmaceutical industry in which he rose to the most senior levels of Pfizer’s global management team. His roles included Vice- President of Pfizer Inc, Executive Vice-President Pfizer Consumer Group, and President of Pfizer’s Consumer Healthcare Division. Mr Renshaw also led the successful integration of Warner Lambert and Pfizer.

CSL’s Chairman, Mr Peter Wade, said that Mr Renshaw’s broad knowledge of the global pharmaceutical industry together with his experience of the Warner Lambert and Pfizer integration, would provide great benefit for CSL as it continues to integrate Aventis Behring into its global operations.

For further information, please contact:

Mr Mark Dehring
Investor Relations Manager
CSL Limited
Ph: + 61 03 9389 2818

Mr Tim Duncan
Ph: +61 3 9600 1979
© 2017 CSL Limited